Glutamate decarboxylase

Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit

Retrieved on: 
Wednesday, November 25, 2020
Diabetes, Organ systems, Branches of biology, Autoimmune diseases, Medical specialties, Latent autoimmune diabetes in adults, Type 1 diabetes, Glutamate decarboxylase, Malang, University of Brawijaya, Autoantibody

Malang, East Java, Indonesia, Nov 25, 2020 - (ACN Newswire) - Brawijaya University (UB) in Malang, East Java has developed an initial screening kit for diabetes.

Key Points: 
  • Malang, East Java, Indonesia, Nov 25, 2020 - (ACN Newswire) - Brawijaya University (UB) in Malang, East Java has developed an initial screening kit for diabetes.
  • The Bioscience Rapid Test GAD65, developed by aresearch team led by Prof. Dr. Aulanni'am, drh, DES, is ready for commercialization and use in early screening for Type I Diabetes Mellitus, before measures and treatment are determined.
  • The reverse-flow immunochromatography-based detection kit identifies the presence of autoantibodies against GAD65, which indicate damage to beta-pancreatic cells, a marker for Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults (LADA).
  • The Bioscience Rapid Test GAD65 is among the downstream products developed as part of the cooperation between Brawijaya University and state-owned pharmaceutical company PT Bio Farma (Persero).